Pancreatic Cancer Research

ResearcherSoochow UniversityActive in the last 2 years

Haijiao Yan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0107-7208; OpenAlex author ID A5050024226. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers

Papers 5

  1. Retraction: MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway. Co-author DOI 10.18632/oncotarget.28806↗
  2. S100 Calcium-Binding Protein P and Cathepsin E as Key Mediators in Pancreatic Cancer Tumorigenesis. Last author DOI 10.3390/biomedicines13112780↗
  3. MiR-629 promotes human pancreatic cancer progression by targeting FOXO3. Co-author DOI 10.1038/cddis.2017.525↗
  4. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway. Co-author DOI 10.18632/oncotarget.5317↗
  5. miR-17-5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells. Co-author DOI 10.1007/s10620-012-2400-4↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shanmiao Gou · 2 shared papers, 2015–2025 · strength 0.32
  2. Chunyou Wang · 2 shared papers, 2015–2025 · strength 0.32
  3. Yu Meng · 1 shared paper, 2025 · strength 0.30
  4. Wei Zhou · 1 shared paper, 2025 · strength 0.27
  5. Tao Liu · 1 shared paper, 2025 · strength 0.27
  6. Jingting Jiang · 2 shared papers, 2012–2017 · strength 0.10
  7. Liangrong Shi · 1 shared paper, 2017 · strength 0.07
  8. Changping Wu · 1 shared paper, 2017 · strength 0.07
  9. Wei Zhou · 1 shared paper, 2015 · strength 0.05
  10. Tao Liu · 1 shared paper, 2015 · strength 0.05
  11. Heshui Wu · 1 shared paper, 2015 · strength 0.05
  12. Changping Wu · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.